Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Venclose digiRF System: A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins

NCT05504070 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT05504070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05504070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Venclose digiRF System: A Post-Market, Multi-Center, Prospective, Interventional Study for Treatment of Chronic Venous Disease of the Great and Small Saphenous Veins and Incompetent Perforator Veins
Lead sponsor
C. R. Bard
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 8, 2023
Completion date
June 30, 2027
Enrollment
203 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous insufficiency, venous reflux